LISA KERLEY: Open Payments
NPI 1700210150 · PAOLA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 9 payments from 8 companies in 2025. Trend: 2023 $737 · 2024 $169 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $42 |
| Seqirus USA Inc | 1 | $22 |
| MML US, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $15 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| GlaxoSmithKline, LLC. | 1 | $14 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, Fluad, ReActiv8, QULIPTA, Cologuard Collection Kit, LEQVIO, SHINGRIX, MOUNJARO.
Industry payments across KS — which companies pay providers there.
